Skip to main content

Table 4 Results of simple logistic regression

From: A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy

Factor

Responsive

Unresponsive

p-Value

OR

95% CI of OR

Lower

Upper

Gender, males

21 (40.4%)

11 (28.9%)

0.265

1.663

0.680

4.063

Age, years

46.75 ± 12.95

41.68 ± 17.3

0.117

1.023

0.994

1.053

Duration of eye symptoms, months

8.75 [4–12]a

24 [12–75]

0.011

0.984

0.971

0.996

Smoking history

28 (53.8%)

19 (50%)

0.718

1.167

0.505

2.696

Family history of TAO

9 (17.3%)

12 (31.6%)

0.118

0.453

0.168

1.223

History of impaired thyroid function

44 (84.6%)

36 (94.7%)

0.149

0.306

0.061

1.530

Pretreatment CAS

4 [3–4]

2 [1–3]

0.001

1.653

1.214

2.250

Restoration of euthyroidism

19 (36.5%)

6 (15.8%)

0.026

3.272

1.150

9.315

  1. OR Odds ratio, CI confidence interval, TAO thyroid-associated ophthalmopathy, CAS clinical activity score, a[interquartile intervals, 25th–75th percentile]
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us